Immunocore Holdings plc (IMCR) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
IMCR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
IMCR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 97.9% | -11.3% | -8.9% |
| 2024 | 97.8% | -22.7% | -16.5% |
| 2023 | 99.6% | -23.9% | -22.2% |
| 2022 | 96.3% | -29.7% | -30.1% |
| 2021 | 100.0% | -478.5% | -493.4% |
Download Data
Export IMCR earnings history in CSV or JSON format
Free sign-in required to download data
Immunocore Holdings plc (IMCR) Earnings Overview
As of May 8, 2026, Immunocore Holdings plc (IMCR) reported trailing twelve-month net income of -$19M, reflecting +48.0% year-over-year growth. The company earned $-0.36 per diluted share over the past four quarters, with a net profit margin of -8.9%.
Looking at the long-term picture, IMCR's historical earnings data spans multiple years. The company achieved its highest annual net income of $20M in fiscal 2015.
Immunocore Holdings plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$315M net income, -794.4% margin), RCUS (-$369M net income, -142.9% margin), AGEN ($115,000 net income, 0.1% margin), IMCR has outperformed on profitability metrics. Compare IMCR vs KYMR →
IMCR Earnings vs Peers
Earnings metrics vs comparable public companies
IMCR Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$26M | +35.3% | -$34M | $-0.53 | -8.9% | -11.3% |
| 2024 | -$41M | +6.7% | -$56M | $-1.02 | -16.5% | -22.7% |
| 2023 | -$44M | -0.7% | -$47M | $-0.89 | -22.2% | -23.9% |
| 2022 | -$43M | +67.4% | -$43M | $-0.95 | -30.1% | -29.7% |
| 2021 | -$133M | -80.1% | -$129M | $-3.00 | -493.4% | -478.5% |
| 2020 | -$74M | +28.7% | -$86M | $-2.33 | -246.0% | -286.2% |
| 2019 | -$104M | -45.1% | -$118M | $-3.81 | -404.9% | -460.9% |
| 2018 | -$72M | -8.9% | -$93M | $-2.62 | -302.8% | -395.1% |
| 2017 | -$66M | -131.5% | -$91M | $-26.74 | -343.1% | -473.7% |
| 2016 | -$28M | -242.9% | -$40M | $-11.60 | -140.5% | -197.3% |
See IMCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IMCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IMCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIMCR — Frequently Asked Questions
Quick answers to the most common questions about buying IMCR stock.
Is IMCR growing earnings?
IMCR EPS is $-0.36, with earnings growth accelerating to +48.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-19M.
What are IMCR's profit margins?
Immunocore Holdings plc net margin is -8.9%, with operating margin at -11.3%. Below-average margins reflect competitive or cost pressures.
How consistent are IMCR's earnings?
IMCR earnings data spans 2013-2025. The accelerating earnings trend is +48.0% YoY. Historical data enables comparison across business cycles.